Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Bristol-Myers Squibb Company · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $36.66B | $36.06B - $37.24B | $12.08B | $4.761 | 11 |
| Dec 2029 | $37.40B | $36.79B - $37.99B | $12.32B | $4.843 | 11 |
| Dec 2028 | $40.98B | $40.97B - $40.98B | $13.50B | $5.39 | 23 |
| Dec 2027 | $46.30B | $45.32B - $47.64B | $15.26B | $6.136 | 21 |
| Dec 2026 | $47.31B | $47.11B - $47.43B | $15.59B | $6.317 | 20 |
| Dec 2025 | $47.99B | $47.74B - $48.19B | $15.82B | $6.114 | 18 |
| Dec 2024 | $47.51B | $47.41B - $47.82B | $15.66B | $0.915 | 17 |
| Dec 2023 | $46.51B | $45.75B - $47.25B | $15.33B | -$3.217 | 8 |
| Dec 2022 | $45.92B | $44.82B - $48.50B | $18.64B | $7.387 | 14 |
| Dec 2021 | $46.46B | $45.35B - $49.07B | $19.63B | $7.47 | 15 |
| Dec 2020 | $42.20B | $41.19B - $44.57B | $3.87B | $6.401 | 15 |
| Dec 2019 | $25.33B | $24.72B - $26.75B | $6.43B | $4.653 | 14 |